Discovery of novel and orally active inhibitors of lck kinase.

被引:0
|
作者
Goldberg, D [1 ]
Butz, T [1 ]
Cardozo, M [1 ]
Eckner, R [1 ]
Hammach, A [1 ]
Huang, J [1 ]
Jakes, S [1 ]
Kapadia, S [1 ]
Lukas, S [1 ]
Morwick, T [1 ]
Moss, N [1 ]
Panzenbeck, M [1 ]
Patel, U [1 ]
Peet, G [1 ]
Peterson, J [1 ]
Prokopowicz, A [1 ]
Snow, RJ [1 ]
Takahashi, H [1 ]
Tan, J [1 ]
Tschantz, M [1 ]
Wang, XJ [1 ]
Xiang, P [1 ]
Zinter, R [1 ]
机构
[1] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
24-MEDI
引用
收藏
页码:U643 / U643
页数:1
相关论文
共 50 条
  • [41] Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: Synthesis, SAR, and in vivo anti-inflammatory activity
    DiMauro, Erin F.
    Newcomb, John
    Nunes, Joseph J.
    Bemis, Jean E.
    Boucher, Christina
    Buchanan, John L.
    Buckner, William H.
    Cee, Victor J.
    Chai, Lilly
    Deak, Holly L.
    Epstein, Linda F.
    Faust, Ted
    Gallant, Paul
    Geuns-Meyer, Stephanie D.
    Gore, Anu
    Gu, Yan
    Henkle, Brad
    Hodous, Brian L.
    Hsieh, Faye
    Huang, Xin
    Kim, Joseph L.
    Lee, Josie H.
    Martin, Matthew W.
    Masse, Craig E.
    McGowan, David C.
    Metz, Daniela
    Mohn, Deanna
    Morgenstern, Kurt A.
    Oliveira-dos-Santos, Antonio
    Patel, Vinod F.
    Powers, David
    Rose, Paul E.
    Schneider, Stephen
    Tomlinson, Susan A.
    Tudor, Yan-Yan
    Turci, Susan M.
    Welcher, Andrew A.
    White, Ryan D.
    Zhao, Huilin
    Zhu, Li
    Zhu, Xiaotian
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (19) : 5671 - 5686
  • [42] 4-azaindoles: Novel inhibitors of p38 MAP kinase.
    Trejo, A
    Arzeno, H
    Browner, M
    Cheng, SA
    Corner, DD
    Dalrymple, S
    Freire-Moar, J
    Lim, J
    Mcintosh, J
    Miller, J
    Myers, PL
    Saunders, J
    Sjogren, EB
    Spellmyer, D
    Warren, SD
    Whiteley, PE
    Zeng, L
    Goldstein, DM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U59 - U59
  • [43] The development of novel and selective p56lck tyrosine kinase inhibitors
    Bullington, JL
    Cameron, JC
    Davis, JE
    Dodd, JH
    Harris, CA
    Henry, JR
    Pellegrino-Gensey, JL
    Rupert, KC
    Siekierka, JJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (18) : 2489 - 2494
  • [44] Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors
    Dwyer, Michael P.
    Paruch, Kamil
    Alvarez, Carmen
    Doll, Ronald J.
    Keertikar, Kerry
    Duca, Jose
    Fischmann, Thierry O.
    Hruza, Alan
    Madison, Vincent
    Lees, Emma
    Parry, David
    Seghezzi, Wolfgang
    Sgambellone, Nicole
    Shanahan, Frances
    Wiswell, Derek
    Guzi, Timothy J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) : 6216 - 6219
  • [45] Discovery of Novel 2-Carbamoyl Morpholine Derivatives as Highly Potent and Orally Active Direct Renin Inhibitors
    Iijima, Daisuke
    Sugama, Hiroshi
    Awai, Nobumasa
    Takahashi, Yoichi
    Togashi, Yuko
    Takebe, Tohru
    Xie, Jianshu
    Shen, Jingkang
    Ke, Ying
    Akatsuka, Hidenori
    Kawaguchi, Takayuki
    Takedomi, Kei
    Kashima, Akiko
    Nishio, Masashi
    Inui, Yosuke
    Yoneda, Hikaru
    Xia, Guangxin
    Iijima, Toru
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (08): : 1351 - 1357
  • [46] Discovery of a novel, selective, and orally bioavailable class of aggrecanase inhibitors.
    Yao, WQ
    Chao, M
    Reddy, G
    Shi, E
    Arner, EC
    Pratta, MA
    Covington, MB
    Tortorella, MD
    Magolda, RL
    Wasserman, ZR
    Wexler, RR
    Decicco, CP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U566 - U566
  • [47] Novel orally active, dibenzampinone-based γ-secretase inhibitors
    Peters, Jens-Uwe
    Galley, Guido
    Jacobsen, Helmut
    Czech, Christian
    David-Pierson, Pascale
    Kitas, Eric A.
    Ozmen, Laurence
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (21) : 5918 - 5923
  • [48] Discovery of novel, potent and orally available MAT2A inhibitors
    Chen, Xuxing
    Li, Jing
    Chen, Yanhong
    CANCER RESEARCH, 2023, 83 (07)
  • [49] Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors
    Sakurada, Isao
    Endo, Toshiya
    Hikita, Katsuyoshi
    Hirabayashi, Tomokazu
    Hosaka, Yoshitaka
    Kato, Yutaka
    Maeda, Yoshitaka
    Matsumoto, Shigeki
    Mizuno, Takashi
    Nagasue, Hiroshi
    Nishimura, Teruyuki
    Shimada, Shunsuke
    Shinozaki, Mikihiko
    Taguchi, Keiko
    Takeuchi, Katsutoshi
    Yokoyama, Tooru
    Hruza, Alan
    Reichert, Paul
    Zhang, Ting
    Wood, Harold B.
    Nakao, Kazunari
    Furusako, Shoji
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (11) : 2622 - 2628
  • [50] Iminopyrimidinones: A novel pharmacophore for the development of orally active renin inhibitors
    McKittrick, Brian A.
    Caldwell, John P.
    Bara, Thomas
    Boykow, George
    Chintala, Madhu
    Clader, John
    Czarniecki, Michael
    Courneya, Brandy
    Duffy, Ruth
    Fleming, Linda
    Giessert, Rachel
    Greenlee, William J.
    Heap, Charles
    Hong, Liwu
    Huang, Ying
    Iserloh, Ulrich
    Josien, Hubert
    Khan, Tanweer
    Korfmacher, Walter
    Liang, Xian
    Mazzola, Robert
    Mitra, Soumya
    Moore, Kristina
    Orth, Peter
    Rajagopalan, Murali
    Roy, Sudipta
    Sakwa, Samuel
    Strickland, Corey
    Vaccaro, Henry
    Voigt, Johannes
    Wang, Hongwu
    Wong, Jesse
    Zhang, Rumin
    Zych, Andrew
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (07) : 1592 - 1596